Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification

Journal of Heart Valve Disease

Volumn 16, Issue 4, 2007, Pages 387-393

  Bozbas, Huseyin ^a   Yildirir, Aylin ^a   Atar, Ilyas ^a   Pirat, Bahar ^a   Eroglu, Serpil ^a   Aydinalp, Alp ^a   Ozin, Bulent ^a   Muderrisoglu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; LIPOPROTEIN A; URIC ACID;

AGE; AGED; AORTA VALVE; ARTICLE; ATHEROSCLEROSIS; BLOOD; CALCINOSIS; CASE CONTROL STUDY; ECHOGRAPHY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; VALVULAR HEART DISEASE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CALCINOSIS; CASE-CONTROL STUDIES; FEMALE; HEART VALVE DISEASES; HOMOCYSTEINE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS; URIC ACID;

EID: 35448974103     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-147 (Pubitemid 29325741)
2. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997;78:472-474 (Pubitemid 27515107)
3. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of degenerative valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-853 (Pubitemid 24242754)
4. Agmon Y, Khandheria BK, Meissner I, et al. Aortic valve sclerosis and aortic atherosclerosis: Different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001;38:827-834 (Pubitemid 32835760)
5. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-3326 (Pubitemid 40875006)
6. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-634 (Pubitemid 27116107)
7. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-1225 (Pubitemid 23106200)
8. Danesh J, Collins R, Peto R. Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000;102:1082-1085
9. Gotoh T, Kuroda T, Yamasawa M, et al. Correlation between lipoprotein (a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol. 1995;76:928-932
10. Glader CA, Birgander LS, Soderberg S, et al. Lipoprotein (a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. Eur Heart J 2003;24:198-208 (Pubitemid 36168475)
11. Mazzone A, Epistolato MC, De Caterina R, et al. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in endstage calcified aortic valve stenosis. J Am Coll Cardiol 2004;43:1670-1676 (Pubitemid 38561351)
12. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-1082 (Pubitemid 32912714)
13. Sanchez PL, Santos JL, Kaski JC, et al. Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 2006;97:90-93 (Pubitemid 41828129)
14. Gerber IL, Stewart RA, Hammett CJ, et al. Effect of aortic valve replacement on c-reactive protein in nonrheumatic aortic stenosis. Am J Cardiol 2003;92:1129-1132 (Pubitemid 37329546)
15. Skowasch D, Schrempf S, Preusse CJ, et al. Tissue resident C reactive protein in degenerative aortic valves: Correlation with serum C reactive protein concentrations and modification by statins. Heart 2006;92:495-498
16. Tribouilloy CM, Peltier M, Iannetta Peltier MC, Trojette F, Andrejak M, Lesbre JP. Plasma homocysteine and severity of thoracic aortic atherosclerosis. Chest 2000;118:1685-1689 (Pubitemid 32001796)
17. Novaro GM, Aronow HD, Mayer-Sabik E, Griffin BP. Plasma homocysteine and calcific aortic valve disease. Heart 2004;90:802-803 (Pubitemid 38813646)
18. Gunduz H, Arinc H, Tamer A, et al. The relation between homocysteine and calcific aortic valve stenosis. Cardiology 2005;103:207-211 (Pubitemid 40875054)
19. Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 2004;27:227-233 (Pubitemid 38594393)
20. Ishizaka N, Ishizaka Y, Toda EI, Hashimoto H, Nagai R, Yamakado M. Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis 2007;192:131-137. (Pubitemid 46602289)
21. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vase Biol 2005;25:1038-1044 (Pubitemid 40627852)
22. Pan WH, Bai CH, Chen JR, Chiu HC. Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension. Stroke 1997;28:88-94
23. Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: The ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol 1996;6:331-340 (Pubitemid 26299025)
24. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987;59:998-999 (Pubitemid 17074253)
25. Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkila J, Tilvis R. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994;15:865-870 (Pubitemid 24223943)
26. Aikawa E, Nahrendorf M, Sosnovik D, et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007;23:377-386 (Pubitemid 46148512)